ALESSANDRA FERRAJOLI to Lymphoma, Mantle-Cell
This is a "connection" page, showing publications ALESSANDRA FERRAJOLI has written about Lymphoma, Mantle-Cell.
Connection Strength
0.064
-
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2006 Sep 01; 12(17):5165-73.
Score: 0.045
-
Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms. Arch Pathol Lab Med. 2014 Jul; 138(7):903-9.
Score: 0.019